Eli Lilly and Co (LLY)

LLY (NYSE:Drugs) EQUITY
$80.32
neg -1.28
-1.57%
Today's Range: 79.68 - 81.11 | LLY Avg Daily Volume: 5,714,600
Last Update: 09/04/15 - 4:01 PM EDT
Volume: 3,405,522
YTD Performance: 18.28%
Open: $80.50
Previous Close: $81.60
52 Week Range: $60.58 - $90.18
Oustanding Shares: 1,108,540,541
Market Cap: 90,689,701,659
6-Month Chart
TheStreet Ratings Grade for LLY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 7 5
Moderate Buy 0 0 1 1
Hold 5 5 4 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.83 1.83 1.71 1.95
Latest Dividend: 0.50
Latest Dividend Yield: 2.44%
Dividend Ex-Date: 08/12/15
Price Earnings Ratio: 42.39
Price Earnings Comparisons:
LLY Sector Avg. S&P 500
42.39 42.40 24.50
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
4.84% 27.20% 81.70%
GROWTH 12 Mo 3 Yr CAGR
Revenue -15.10 -0.19 -0.07
Net Income -49.00 -0.45 -0.18
EPS -48.50 -0.43 -0.17
Earnings for LLY:
EBITDA 4.71B
Revenue 19.62B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $0.75 $0.76 $3.27 $3.59
Number of Analysts 9 7 12 12
High Estimate $0.81 $0.82 $3.33 $3.91
Low Estimate $0.68 $0.68 $3.21 $3.31
Prior Year $0.66 $0.75 $2.78 $3.27
Growth Rate (Year over Year) 13.97% 0.76% 17.75% 9.78%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Timothy Collins

 | Aug 25, 2015 | 9:03 AM EDT

Today may be a good opportunity to exit some names.

By

Doug Kass

 | Aug 20, 2015 | 10:40 AM EDT
Eli Lilly (LLY) is up 5% following positive top-line Jardiance results for diabetes. Meanwhile, Merck (MRK) is down 4% on competitive concerns.
By

David Peltier

 | Jul 22, 2015 | 4:41 PM EDT

Tech, telecom stocks lead major averages lower.

By

Jim Cramer

 | Jul 20, 2015 | 7:33 AM EDT

Don't make a learning week a gambling week.

By

Sebastian Silva

 | Jul 19, 2015 | 7:39 PM EDT

Futures are mixed as quarterly results begin to obscure Greece.

bullishEli Lilly numbers raised at BMO

Jul 16, 2015 | 7:37 AM EDT

Shares of LLY now seen reaching $92, according to BMO Capital. Estimates also increased, given higher expectations for Sola. Market Perform rating. 

bullishEli Lilly numbers increased at Leerink

Jun 26, 2015 | 7:16 AM EDT

LLY estimates were raised through 2016, Leerink Partners said. Have a more bullish outlook for the pipeline. Outperform rating and new $92 price target. 

By

Roger Arnold

 | Jun 25, 2015 | 1:46 PM EDT

As health-care stocks rally, it's time for politicians to move on.

bullishEli Lilly upgraded at BofA/Merrill

Jun 25, 2015 | 7:20 AM EDT

LLY was upgraded from Neutral to Buy, Bank of America/Merrill Lynch said. $101 price target. Estimates also increased for several pipeline products. 

By

Robert Lang

 | Jun 10, 2015 | 10:00 AM EDT

LLY's chart shows stellar price moves on very strong turnover and great Relative Strength.

A pair of eveningstar patterns have formed on the S&P 500 index chart. The eveningstar...

As I mentioned about a week ago, it appears BGB might trace out of its downtrend.

Micron appears headed for a positive close. The stock is up slightly today and is wor...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.